Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-25-011813

Options or other derivatives

  • Director acquired 26,304 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Louie Ngar Yee Director 2025-04-04 Grant or award · Stock Options +26,304 26,304 D: show line 1 in the form
Loading xslF345X05/form4.xml…